Clinical Trials Logo

Filter by:
NCT ID: NCT03445923 Terminated - Infertility Clinical Trials

Can Time-lapse Parameters be Used to Predict Pregnancy of Human Embryos?

Start date: May 29, 2018
Phase: N/A
Study type: Interventional

All patients starting an IVF-treatment at the clinics, and meeting the inclusion criteria, will be offered to participate in the study. Randomization will be performed on day 5 and the patients will be allocated into either morphology only group or time-lapse group. Embryos will be cultured to day five according to the clinics own routines. All embryos in both groups will be cultured using time-lapse incubation. In the control group the embryo selection will be based only on traditional morphological evaluation and in the treatment group a time-lapse selection model (KID Score day 5) will be used to select the embryo.

NCT ID: NCT03445806 Terminated - Clinical trials for Glaucoma, Open-Angle

IOP Monitoring After Trabeculectomy Using iCare Home

Start date: February 26, 2018
Phase:
Study type: Observational

The purpose of this study is to investigate how much trabeculectomy influences intraocular pressure (IOP) fluctuations measured with iCare Home rebound tonometry (RTHome) in patients with primary open-angle glaucoma (POAG) or pseudo-exfoliation glaucoma (PEX).

NCT ID: NCT03445533 Terminated - Metastatic Melanoma Clinical Trials

A Study of Tilsotolimod in Combo With Ipilimumab vs Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma

Start date: May 30, 2018
Phase: Phase 3
Study type: Interventional

A Phase 3 comparison of ipilimumab with and without IMO-2125 in advanced melanoma

NCT ID: NCT03444675 Recruiting - Clinical trials for Transplant; Complication, Rejection

The Endoscopic Assesment of Intestinal Grafts

INTEGRATE
Start date: April 29, 2014
Phase:
Study type: Observational

The study validates prospectively a new endoscopic scoring system (Gothenburg Intestinal Transplant Endoscopy Score, GITES) designed to summarize and stratify the abnormal ileal endoscopic findings after intestinal transplantation. GITES is a five-tier, four grade score which asseses mucosal friability, mucosal erythema and mucosal injury (ulcerations) as well as villous changes according to severity. These features (i.e., endoscopic descriptors) are also grouped from mild to very severe in the same sequence as observed during the progression of several pathologic conditions encountered after intestinal transplantation (acute rejection, infectious enteritis).

NCT ID: NCT03444623 Recruiting - Clinical trials for Rheumatoid Arthritis

Survivin as Predictive Biomarker for RA

SurviPred
Start date: June 2013
Phase:
Study type: Observational

Purpose: to examine the possibility of using the onco-protein survivin as a predictive biomarker for identifying individuals at risk of developing rheumatoid arthritis within a cohort of patients seeking treatment for joint pain/stiffness. Secondly, to study survivin as a prognostic marker for joint destruction, refractory and highly active disease in patients with established RA.

NCT ID: NCT03444545 Completed - Cardiac Output, Low Clinical Trials

Continous Cardiac Output - Non-Invasive Evaluation (CONNIE)

CONNIE
Start date: October 29, 2015
Phase:
Study type: Observational

The capnodynamic method non-invasively calculates effective pulmonary blood flow (EPBF) continuously during surgery. In this study EPBF is compared to cardiac output (CO) measured with Transpulmonary Thermodilution (TPTD) att baseline and during hemodynamic changes in patients scheduled for open abdominal surgery at the Karolinska University Hospital, Solna, Sweden.

NCT ID: NCT03443973 Terminated - Alzheimer Disease Clinical Trials

Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

Start date: August 22, 2018
Phase: Phase 3
Study type: Interventional

This randomized, double-blind, placebo-controlled, parallel group study will evaluate the efficacy and safety of gantenerumab versus placebo in participants with early (prodromal to mild) AD. All participants must show evidence of beta-amyloid pathology. Eligible participants will be randomized 1:1 to receive either subcutaneous (SC) injection of gantenerumab or placebo. The primary efficacy assessment will be performed at the end of the double blind period at week 116. Participants will then be offered to enter into an open-label extension (OLE). Participants not willing to go to the OLE will participate in a long term follow-up period for up to 50 weeks after the last gantenerumab dose.

NCT ID: NCT03443011 Completed - Diverticulitis Clinical Trials

Diagnostics in Diverticulitis (DIDit)

Start date: January 19, 2017
Phase: N/A
Study type: Interventional

This study focuses on if low dose CT without intravenous contrast has a high enough specificity and sensitivity for acute diverticulitis that it can be used as the primary diagnostic method instead of a full dose CT with intravenous contrast which is the standard method in Sweden.

NCT ID: NCT03442257 Completed - Hypertension Clinical Trials

Text Message Intervention for Prevention of Cardiovascular Disease in Primary Care Patients With Hypertension

PUSH-ME
Start date: March 19, 2018
Phase: N/A
Study type: Interventional

The primary objective of the study is to examine the impact of lifestyle advices, administered through regularly sent SMS, on hypertension in a primary health care setting. The secondary objective is to evaluate changes in other cardiovascular risk factors and general health, e.g. tobacco use, obesity, blood lipids, blood glucose, self-rated health and health-related quality of life.

NCT ID: NCT03441490 Completed - Anxiety Clinical Trials

Internet-delivered Cognitive Behavioural Therapy for Adolescents With Anxiety

Start date: February 8, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effects of learning support and chat on treatment outcome in internet-administrated cognitive behaviour therapy (ICBT) for adolescents with anxiety.